Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05480384
Title Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2- Positive Cancers of the Esophagus and Gastroesophageal Junction
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Brown University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.